Touhami Omar, Allen Lisa, Flores Mendoza Homero, Murphy M Alix, Hobson Sebastian Rupert
Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Centre Intégré Universitaire de Santé et Services Sociaux CIUSSS du Saguenay-Lac-Saint-Jean, Sherbrooke University, Sherbrooke, Quebec, Canada
Department of Obstetrics and Gynecology, University of Toronto Faculty of Medicine, Toronto, Ontario, Canada.
Int J Gynecol Cancer. 2022 Jun 6;32(6):788-798. doi: 10.1136/ijgc-2021-003325.
Placenta accreta spectrum disorders are a major risk factor for severe postpartum hemorrhage and maternal death worldwide, with a rapidly growing incidence in recent decades due to increasing rates of cesarean section. Placenta accreta spectrum disorders represent a complex surgical challenge, with the primary concern of massive obstetrical hemorrhagic sequelae and organ damage, occurring in the context of potentially significant anatomical and physiological changes of pregnancy. Most international obstetrical organizations have published guidelines on placenta accreta spectrum, embracing the creation of regionalized 'Centers of Excellence' in the diagnosis and management of placenta accreta spectrum, which includes a dedicated multidisciplinary surgical team. One mandatory criterion for these Centers of Excellence is the presence of a surgeon experienced in complex pelvic surgeries. Indeed, many institutions in the United States and worldwide rely on gynecologic oncologists in the surgical management of placenta accreta spectrum due to their experience and skills in complex pelvic surgery. Surgical management of placenta accreta spectrum frequently includes challenging pelvic dissection in regions with distortion of anatomy alongside large aberrant neovascularization. With a goal of definitive management through cesarean hysterectomy, surgeons require a systematic and thoughtful approach to promote prevention of urologic injuries, embrace measures to secure challenging hemostasis and, in selected cases, employ conservative management where indicated or desired. In this review recommendations are made for gynecologic oncologists regarding the management and important considerations in the successful care of placenta accreta spectrum disorders. Where required, gynecologic oncologists are encouraged to be proactively involved in the management of placenta accreta spectrum, not only intra-operatively, but also in the development of clinical protocols, guidelines, and pre-operative counseling of patients, as a 'call if needed' approach is suboptimal for this potentially major and life-threatening condition.
胎盘植入谱系疾病是全球范围内严重产后出血和孕产妇死亡的主要危险因素,近几十年来,由于剖宫产率上升,其发病率迅速增长。胎盘植入谱系疾病是一项复杂的外科挑战,主要问题是产科大出血后遗症和器官损伤,这些情况发生在妊娠可能出现的重大解剖和生理变化的背景下。大多数国际产科组织都发布了关于胎盘植入谱系的指南,提倡在胎盘植入谱系的诊断和管理方面设立区域化的“卓越中心”,其中包括一个专门的多学科手术团队。这些卓越中心的一项强制性标准是要有一位在复杂盆腔手术方面有经验的外科医生。事实上,美国和全球的许多机构在胎盘植入谱系的外科管理中依赖妇科肿瘤学家,因为他们在复杂盆腔手术方面有经验和技能。胎盘植入谱系的外科管理通常包括在解剖结构扭曲且伴有大量异常新生血管的区域进行具有挑战性的盆腔解剖。以剖宫产子宫切除术进行确定性治疗为目标,外科医生需要一种系统且周全的方法来预防泌尿系统损伤,采取措施确保难以控制的止血,并在某些情况下,根据指征或需求采用保守治疗。在本综述中,针对妇科肿瘤学家在成功治疗胎盘植入谱系疾病方面的管理及重要注意事项提出了建议。在需要时,鼓励妇科肿瘤学家积极参与胎盘植入谱系的管理,不仅在术中,而且在临床方案、指南的制定以及患者的术前咨询方面,因为对于这种可能严重且危及生命的情况,“按需呼叫”的方法并不理想。